Jump to content

Wikipedia:WikiProject Pharmacology/Log/2009-11-04

Add links
From Wikipedia, the free encyclopedia

Standard header for logs from CheMoBot

  • 01:17:21 (5, 5, 5) (EDIT) User:CheMoBot (contribs, talk) edited Imatinib (diff, hist)
    Added: 'verifiedrevid' ('309829968' -> '313070026', SET '')
  • 01:35:05 (3, 2, 4) (EDIT) User:Davidtfull (contribs, talk) edited Levofloxacin (diff, hist)
    Added links: http://fqresearch.org/pdf_files/62nd_fda_meeting.pdf
  • 01:42:56 (3, 2, 4) (EDIT) User:MONGO (contribs, talk) edited Methylphenidate (diff, hist)
    Added links: http://www.dea.gov/pubs/cngrtest/ct051600.htm, http://www.cjcp.ca/pdf/CJCP_05-012_e50.pdf, http://www.medpagetoday.com/ProductAlert/Prescriptions/tb/3027.
  • 02:04:50 (3, 4, 5) (EDIT) User:Blancer707 (contribs, talk) edited Lindane (diff, hist)
    Changed: 'legal_status' ('Banned internationally by 2009 Stockholm Convention on Persistent Organic Pollutants' -> 'The 2009 Stockholm Convention on Persistent Organic Pollutants, bans lindane in ratified countries, with a specific exemption for use of lindane as a human health pharmaceutical for the control of head lice and scabies as second-line treatment <ref>Report of the Conference of the Parties of the Stockholm Convention on Persistent Organic Pollutants on the work of its fourth meeting. Convention on Persistent Organic Pollutants. Fourth meeting, Geneva, 4–8 May 2009. [http://chm.pops.int/Portals/0/Repository/COP4/UNEP-POPS-COP.4-38.English.pdf http://chm.pops.int/Portals/0/Repository/COP4/UNEP-POPS-COP.4-38.English.pdf]</ref> In the U.S., pharmaceutical lindane FDA approved for second-line treatment of scabies and head lice; agricultural uses cancelled by the EPA in 2006 (use of stockpiles allowed through 2009) <ref name="EPAREDADD">U.S. EPA. Addendum to the 2002 Lindane Reregistration Eligibility Decision (RED). July 2006. http://www.epa.gov/oppsrrd1/REDs/lindane_red_addendum.pdf</ref>', SET 'FDA-approved for the second-line treatment of scabies, pubic lice (crabs) and head lice')
  • 02:04:50 (3, 2, 4) (EDIT) User:Blancer707 (contribs, talk) edited Lindane (diff, hist)
    Added links: http://chm.pops.int/Portals/0/Repository/COP4/UNEP-POPS-COP.4-38.English.pdf, http://chm.pops.int/Portals/0/Repository/COP4/UNEP-POPS-COP.4-38.English.pdf, http://www.epa.gov/oppsrrd1/REDs/lindane_red_addendum.pdf
  • 02:06:11 (2, 4, 5) (EDIT) User:Blancer707 (contribs, talk) edited Lindane (diff, hist)
    Changed: 'legal_status' ('The 2009 Stockholm Convention on Persistent Organic Pollutants, bans lindane in ratified countries, with a specific exemption for use of lindane as a human health pharmaceutical for the control of head lice and scabies as second-line treatment <ref>Report of the Conference of the Parties of the Stockholm Convention on Persistent Organic Pollutants on the work of its fourth meeting. Convention on Persistent Organic Pollutants. Fourth meeting, Geneva, 4–8 May 2009. [http://chm.pops.int/Portals/0/Repository/COP4/UNEP-POPS-COP.4-38.English.pdf http://chm.pops.int/Portals/0/Repository/COP4/UNEP-POPS-COP.4-38.English.pdf]</ref> In the U.S., pharmaceutical lindane FDA approved for second-line treatment of scabies and head lice; agricultural uses cancelled by the EPA in 2006 (use of stockpiles allowed through 2009) <ref name="EPAREDADD">U.S. EPA. Addendum to the 2002 Lindane Reregistration Eligibility Decision (RED). July 2006. http://www.epa.gov/oppsrrd1/REDs/lindane_red_addendum.pdf</ref>' -> 'The 2009 Stockholm Convention on Persistent Organic Pollutants bans lindane in ratified countries, with a specific exemption for use of lindane as a human health pharmaceutical for the control of head lice and scabies as second-line treatment <ref>Report of the Conference of the Parties of the Stockholm Convention on Persistent Organic Pollutants on the work of its fourth meeting. Convention on Persistent Organic Pollutants. Fourth meeting, Geneva, 4–8 May 2009. [http://chm.pops.int/Portals/0/Repository/COP4/UNEP-POPS-COP.4-38.English.pdf http://chm.pops.int/Portals/0/Repository/COP4/UNEP-POPS-COP.4-38.English.pdf]</ref> In the U.S., pharmaceutical lindane FDA approved for second-line treatment of scabies and head lice; agricultural uses cancelled by the EPA in 2006 (use of stockpiles allowed through 2009) <ref name="EPAREDADD">U.S. EPA. Addendum to the 2002 Lindane Reregistration Eligibility Decision (RED). July 2006. http://www.epa.gov/oppsrrd1/REDs/lindane_red_addendum.pdf</ref>', SET 'FDA-approved for
  • 02:15:11 (2, 4, 5) (EDIT) User:Blancer707 (contribs, talk) edited Lindane (diff, hist)
    Changed: 'legal_status' ('The 2009 Stockholm Convention on Persistent Organic Pollutants bans lindane in ratified countries, with a specific exemption for use of lindane as a human health pharmaceutical for the control of head lice and scabies as second-line treatment <ref>Report of the Conference of the Parties of the Stockholm Convention on Persistent Organic Pollutants on the work of its fourth meeting. Convention on Persistent Organic Pollutants. Fourth meeting, Geneva, 4–8 May 2009. [http://chm.pops.int/Portals/0/Repository/COP4/UNEP-POPS-COP.4-38.English.pdf http://chm.pops.int/Portals/0/Repository/COP4/UNEP-POPS-COP.4-38.English.pdf]</ref> In the U.S., pharmaceutical lindane FDA approved for second-line treatment of scabies and head lice; agricultural uses cancelled by the EPA in 2006 (use of stockpiles allowed through 2009) <ref name="EPAREDADD">U.S. EPA. Addendum to the 2002 Lindane Reregistration Eligibility Decision (RED). July 2006. http://www.epa.gov/oppsrrd1/REDs/lindane_red_addendum.pdf</ref>' -> 'Listed in 2009 under the Stockholm Convention on Persistent Organic Pollutants, which bans lindane in ratified countries, with a specific exemption for use of lindane as a human health pharmaceutical for the control of head lice and scabies as second-line treatment <ref>Report of the Conference of the Parties of the Stockholm Convention on Persistent Organic Pollutants on the work of its fourth meeting. Convention on Persistent Organic Pollutants. Fourth meeting, Geneva, 4–8 May 2009. [http://chm.pops.int/Portals/0/Repository/COP4/UNEP-POPS-COP.4-38.English.pdf http://chm.pops.int/Portals/0/Repository/COP4/UNEP-POPS-COP.4-38.English.pdf]</ref> In the U.S., pharmaceutical lindane FDA approved for second-line treatment of scabies and head lice; agricultural uses cancelled by the EPA in 2006 (use of stockpiles allowed through 2009) <ref name="EPAREDADD">U.S. EPA. Addendum to the 2002 Lindane Reregistration Eligibility Decision (RED). July 2006. http://www.epa.gov/oppsrrd1/REDs/lindane_red_addendum.pdf</ref>',
  • 02:48:51 (3, 2, 4) (EDIT) User:Nbauman (contribs, talk) edited Imatinib (diff, hist)
    Added links: http://www.nytimes.com/2009/11/03/science/03conv.html
  • 03:39:30 (3, 2, 4) (EDIT) User:Blancer707 (contribs, talk) edited Lindane (diff, hist)
    Added links: http://www.pops.int/documents/meetings/poprc/drprofile/drme/DraftRME_Lindane.pdf, http://www.inchem.org/documents/iarc/suppl7/hexachlorocyclohexanes.html, http://www.lindane.com/pdf/EPA_Cancer_Assessment_of_Lindane2001.pdf, http://www.lindane.com/pdf/EPA_Cancer_Assessment_of_Lindane2001.pdf
  • 03:47:39 (3, 2, 4) (EDIT) User:218.214.18.240 (contribs, talk) edited Celecoxib (diff, hist)
    Added links: http://www.fda.gov/downloads/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm124654.pdf
  • 04:00:49 (3, 2, 4) (EDIT) User:Maasnfi (contribs, talk) edited Saxagliptin (diff, hist)
    Added links: http://adisonline.com/drugs/abstract/2009/69150/Saxagliptin.5.aspx
  • 04:22:24 (3, 2, 4) (EDIT) User:Wcp07 (contribs, talk) edited MDMA (diff, hist)
    Added links: http://jop.sagepub.com/cgi/pmidlookup?view=long&pmid=14870950
  • 06:36:48 (3, 2, 4) (EDIT) User:213.10.165.135 (contribs, talk) edited Artemisinin (diff, hist)
    Added links: http://www.a2s2.org
  • 06:45:38 (3, 2, 4) (EDIT) User:Voidxor (contribs, talk) edited Co-codamol (diff, hist)
    Added links: http://www.ctv.ca/servlet/ArticleNews/story/CTVNews/20080820/tylenol_3_breastfeeding_080820/20080820?hub=Canada
  • 07:13:07 (2, 3, 5) (EDIT) User:GregU (contribs, talk) edited User:GregU/Sandbox (diff, hist)
    Changed: 'realboxname' ('drugbox' -> '')
  • 07:13:07 (2, 3, 5) (EDIT) User:GregU (contribs, talk) edited User:GregU/Sandbox (diff, hist)
    Changed: 'boxname' ('drugbox' -> '')
  • 07:13:08 (2, 3, 5) (EDIT) User:GregU (contribs, talk) edited User:GregU/Sandbox (diff, hist)
    Changed: 'image' ('Bupropion.png' -> '')
  • 07:13:08 (2, 3, 5) (EDIT) User:GregU (contribs, talk) edited User:GregU/Sandbox (diff, hist)
    Changed: 'image2' ('Bupropion-3d-CPK.png' -> '')
  • 07:13:08 (2, 3, 5) (EDIT) User:GregU (contribs, talk) edited User:GregU/Sandbox (diff, hist)
    Changed: 'width' ('135' -> '')
  • 07:13:09 (2, 3, 5) (EDIT) User:GregU (contribs, talk) edited User:GregU/Sandbox (diff, hist)
    Changed: 'bioavailability' ('5 to 20% in animals; no studies in humans' -> '')
  • 07:13:09 (2, 3, 5) (EDIT) User:GregU (contribs, talk) edited User:GregU/Sandbox (diff, hist)
    Changed: 'metabolism' ('[[Liver|Hepatic]]' -> '')
  • 07:13:09 (2, 3, 5) (EDIT) User:GregU (contribs, talk) edited User:GregU/Sandbox (diff, hist)
    Changed: 'elimination_half-life' ('20 hours' -> '')
  • 07:13:09 (2, 3, 5) (EDIT) User:GregU (contribs, talk) edited User:GregU/Sandbox (diff, hist)
    Changed: 'excretion' ('[[Kidney|Renal]] (87%), fecal (10%)' -> '')
  • 07:13:10 (2, 3, 5) (EDIT) User:GregU (contribs, talk) edited User:GregU/Sandbox (diff, hist)
    Changed: 'pregnancy_US' ('B' -> '')
  • 07:13:10 (2, 3, 5) (EDIT) User:GregU (contribs, talk) edited User:GregU/Sandbox (diff, hist)
    Changed: 'legal_US' ('Rx-only' -> '')
  • 07:13:10 (2, 3, 5) (EDIT) User:GregU (contribs, talk) edited User:GregU/Sandbox (diff, hist)
    Changed: 'legal_UK' ('POM' -> '')
  • 07:13:11 (4, 3, 5) (EDIT) User:GregU (contribs, talk) edited User:GregU/Sandbox (diff, hist)
    Changed: 'IUPAC_name' ('(±)-1-(3-chlorophenyl)-2-[(1,1-dimethylethyl)amino]-<BR>1-propanone' -> '')
  • 07:13:11 (4, 3, 5) (EDIT) User:GregU (contribs, talk) edited User:GregU/Sandbox (diff, hist)
    Changed: 'molecular_weight' ('239.74 g/mol' -> '')
  • 07:13:11 (4, 3, 5) (EDIT) User:GregU (contribs, talk) edited User:GregU/Sandbox (diff, hist)
    Changed: 'DrugBank' ('APRD00621' -> '')
  • 07:13:11 (4, 3, 5) (EDIT) User:GregU (contribs, talk) edited User:GregU/Sandbox (diff, hist)
    Changed: 'ATC_prefix' ('N07' -> '')
  • 07:13:12 (4, 3, 5) (EDIT) User:GregU (contribs, talk) edited User:GregU/Sandbox (diff, hist)
    Changed: 'ATC_suffix' ('BA02' -> '')
  • 07:13:12 (4, 3, 5) (EDIT) User:GregU (contribs, talk) edited User:GregU/Sandbox (diff, hist)
    Changed: 'C' ('13' -> '')
  • 07:13:12 (4, 3, 5) (EDIT) User:GregU (contribs, talk) edited User:GregU/Sandbox (diff, hist)
    Changed: 'H' ('18' -> '')
  • 07:13:13 (4, 3, 5) (EDIT) User:GregU (contribs, talk) edited User:GregU/Sandbox (diff, hist)
    Changed: 'N' ('1' -> '')
  • 07:13:13 (4, 3, 5) (EDIT) User:GregU (contribs, talk) edited User:GregU/Sandbox (diff, hist)
    Changed: 'O' ('1' -> '')
  • 07:13:13 (4, 3, 5) (EDIT) User:GregU (contribs, talk) edited User:GregU/Sandbox (diff, hist)
    Changed: 'Cl' ('1' -> '')
  • 07:13:14 (4, 3, 5) (EDIT) User:GregU (contribs, talk) edited User:GregU/Sandbox (diff, hist)
    Changed: 'PubChem' ('444' -> '')
  • 07:13:14 (5, 3, 5) (EDIT) User:GregU (contribs, talk) edited User:GregU/Sandbox (diff, hist)
    Changed: 'CAS_number' ('34841-39-9' -> '')
  • 07:14:14 (3, 2, 4) (EDIT) User:Editor182 (contribs, talk) edited Methylphenidate (diff, hist)
    Added links: http://books.google.com.au/books?id=kLBwj7i6CMwC&pg=PT136&lpg=PT136&dq=methylphenidate+lethal+dose+range&source=bl&ots=LMp5G6UOkx&sig=yOrZs1lIRraVF_UcU-5mqegeHms&hl=en&ei=FP7wSo_yGtaSkQWOy7iWBw&sa=X&oi=book_result&ct=result&resnum=5&ved=0CBsQ6AEwBA#v=onepage&q=methylphenidate%20lethal%20dose%20range&f=false
  • 07:59:39 (3, 2, 4) (EDIT) User:Cory.kniep (contribs, talk) edited Cocaethylene (diff, hist)
    Added links: http://drugabuse.gov/cocaethylene
  • 08:32:40 (3, 2, 4) (EDIT) User:Chris Capoccia (contribs, talk) edited Caroverine (diff, hist)
    Added links: http://iospress.metapress.com/openurl.asp?genre=article&issn=0951-6433&volume=19&issue=1&spage=79
  • 08:33:32 (5, 5, 5) (EDIT) User:CheMoBot (contribs, talk) edited Trihexyphenidyl (diff, hist)
    Added: 'verifiedrevid' ('' -> '312955639', SET '')
  • 08:33:33 (5, 5, 5) (EDIT) User:CheMoBot (contribs, talk) edited Trihexyphenidyl (diff, hist)
    Added: 'CASNo_Ref' ('' -> '{{cascite}}', SET '')
  • 10:27:46 (3, 2, 4) (EDIT) User:159.149.151.26 (contribs, talk) edited Fluvoxamine (diff, hist)
    Added links: http://www.solvaypharmaceuticals-us.com/newsroom/pressreleases/0,,14517-2-0,00.htm
  • 10:36:35 (3, 2, 4) (EDIT) User:Relum Evets (contribs, talk) edited Mephedrone (diff, hist)
    Added links: http://www.crew2000.org.uk/index.php?mact=Uploads,cntnt01,getfile,0&cntnt01showtemplate=false&cntnt01upload_id=63&cntnt01returnid=112/
  • 15:37:00 (2, 3, 4) (EDIT) User:Anypodetos (contribs, talk) edited Zalutumumab (diff, hist)
    Changed: 'source' ('Human' -> '[[Human]]')
  • 15:37:01 (2, 3, 4) (EDIT) User:Anypodetos (contribs, talk) edited Zalutumumab (diff, hist)
    Changed: 'target' ('Human Epidermal Growth Factor Receptor' -> '[[Epidermal growth factor receptor]]')
  • 15:37:01 (4, 3, 4) (EDIT) User:Anypodetos (contribs, talk) edited Zalutumumab (diff, hist)
    Changed: 'molecular_weight' ('148 kD' -> '148 [[kDa]]')
  • 17:39:14 (3, 2, 4) (EDIT) User:Yilloslime (contribs, talk) edited Lindane (diff, hist)
    Added links: http://www.fda.gov/Drugs/DrugSafety/PublicHealthAdvisories/ucm052201.htm
  • 19:27:12 (3, 2, 4) (EDIT) User:MunkyJuce69 (contribs, talk) edited Tramadol (diff, hist)
    Added links: http://www.buytramadolhcl.net/new-legislation-aimed-at-the-military.html
  • 20:38:45 (5, 5, 5) (EDIT) User:CheMoBot (contribs, talk) edited Entacapone (diff, hist)
    Added: 'verifiedrevid' ('' -> '294207507', SET '')
  • 20:38:45 (5, 5, 5) (EDIT) User:CheMoBot (contribs, talk) edited Entacapone (diff, hist)
    Added: 'CASNo_Ref' ('' -> '{{cascite}}', SET '')
  • 23:40:44 (3, 2, 4) (EDIT) User:Literaturegeek (contribs, talk) edited Levofloxacin (diff, hist)
    Added links: http://aac.asm.org/cgi/reprint/29/6/1073.pdf, http://www.academy.org.uk/pharmacy/fluoroq.htm, http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-50532003000500014&lng=es&nrm=iso&tlng=es, http://jbcs.sbq.org.br/jbcs/2003/v14_n5/13-048-02.pdf
  • 23:44:21 (2, 3, 5) (EDIT) User:130.74.219.199 (contribs, talk) edited Clortermine (diff, hist)
    Changed: 'legal_status' ('' -> 'Schedule III')
  • 23:51:48 (3, 2, 4) (EDIT) User:Literaturegeek (contribs, talk) edited Moxifloxacin (diff, hist)
    Added links: http://www.jstor.org/pss/4454399
  • 23:52:14 (3, 2, 4) (EDIT) User:Literaturegeek (contribs, talk) edited Ciprofloxacin (diff, hist)
    Added links: http://www.jstor.org/pss/4454399
  • 23:53:21 (3, 2, 4) (EDIT) User:Literaturegeek (contribs, talk) edited Levofloxacin (diff, hist)
    Added links: http://www.jstor.org/pss/4454399
Retrieved from "https://en.wikipedia.org/w/index.php?title=Wikipedia:WikiProject_Pharmacology/Log/2009-11-04&oldid=323991429"